Prior to the Phase III study, there was no formal agreement to make Havrix widely available in Thailand. ... While there was no promise about what the prices would be for the private market, SmithKline Beecham Biologicals had previously utilized tiered pricing on vaccines. ... able to afford the vaccine, committing to registering and selling it on the private market does not seem to be areasonably available.
|Title||:||Die Deklaration von Helsinki|
|Author||:||Hans-Jörg Ehni, Urban Wiesing|
|Publisher||:||Deutscher Ärzteverlag - 2012|